|
|
| LMBL1_HUMAN |
L3MBTL1 |
Lethal(3)malignant brain tumor-like protein 1 |
7.694e-186 |
0.51
|
| LMBL3_HUMAN |
L3MBTL3 |
Lethal(3)malignant brain tumor-like protein 3 |
9.804e-171 |
0.51
|
| MBTD1_HUMAN |
MBTD1 |
MBT domain-containing protein 1 |
1.366e-116 |
0.48
|
| TP53B_HUMAN |
TP53BP1 |
TP53-binding protein 1 |
2.206e-85 |
0.46
|
| NEMO_HUMAN |
IKBKG |
NF-kappa-B essential modulator |
5.118e-63 |
0.39
|
| LMBL4_HUMAN |
L3MBTL4 |
Lethal(3)malignant brain tumor-like protein 4 |
1.259e-52 |
0.42
|
| BKRB1_MACFA |
BDKRB1 |
B1 bradykinin receptor |
8.229e-49 |
0.42
|
| OGRL1_HUMAN |
OGFRL1 |
Opioid growth factor receptor-like protein 1 |
1.249e-47 |
0.35
|
| CALCA_HUMAN |
CALCA |
Calcitonin gene-related peptide 1 |
9.209e-46 |
0.31
|
| CCR3_MACMU |
CCR3 |
C-C chemokine receptor type 3 |
1.718e-42 |
0.34
|
| V1BR_HUMAN |
AVPR1B |
Vasopressin V1b receptor |
8.575e-39 |
0.34
|
| TRPV4_RAT |
Trpv4 |
Transient receptor potential cation channel subfamily V member 4 |
4.233e-38 |
0.31
|
| ACACA_HUMAN |
ACACA |
Acetyl-CoA carboxylase 1 |
4.578e-37 |
0.36
|
| Q8MHZ5_SHEEP |
|
Ghrelin/growth hormone secretagogue receptor |
2.333e-33 |
0.32
|
| NPC1_HUMAN |
NPC1 |
NPC intracellular cholesterol transporter 1 |
3.239e-33 |
0.34
|
| HRH3_HUMAN |
HRH3 |
Histamine H3 receptor |
8.936e-31 |
0.39
|
| Q6A2E2_AEDAE |
ace-1 |
Acetylcholinesterase |
5.518e-23 |
0.28
|
| ACM2_HUMAN |
CHRM2 |
Muscarinic acetylcholine receptor M2 |
1.889e-22 |
0.35
|
| V1AR_RAT |
Avpr1a |
Vasopressin V1a receptor |
1.218e-21 |
0.35
|
| KDM2A_HUMAN |
KDM2A |
Lysine-specific demethylase 2A |
2.785e-20 |
0.34
|
| AGTR1_BOVIN |
AGTR1 |
Type-1 angiotensin II receptor |
4.218e-20 |
0.33
|
| Q1HEC0_RAT |
|
Acetyl-Coenzyme A carboxylase 2 |
6.896e-20 |
0.32
|
| O70424_RAT |
|
Neuropeptide Y-Y2 receptor |
2.301e-18 |
0.29
|
| DUS22_HUMAN |
DUSP22 |
Dual specificity protein phosphatase 22 |
2.106e-17 |
0.30
|
| A8K2H7_HUMAN |
C3AR1 |
Complement component 3a receptor 1, isoform CRA_a |
3.055e-17 |
0.33
|
| CNR2_HUMAN |
CNR2 |
Cannabinoid receptor 2 |
1.11e-16 |
0.49
|
| PGDH_HUMAN |
HPGD |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] |
3.331e-16 |
0.44
|
| KDM5C_HUMAN |
KDM5C |
Lysine-specific demethylase 5C |
1.11e-15 |
0.34
|
| TRPV4_HUMAN |
TRPV4 |
Transient receptor potential cation channel subfamily V member 4 |
2.109e-15 |
0.31
|
| FAS_HUMAN |
FASN |
Fatty acid synthase |
2.554e-15 |
0.33
|
| CCR3_HUMAN |
CCR3 |
C-C chemokine receptor type 3 |
4.441e-15 |
0.38
|
| ACACA_RAT |
Acaca |
Acetyl-CoA carboxylase 1 |
1.066e-14 |
0.32
|
| CNR1_RAT |
Cnr1 |
Cannabinoid receptor 1 |
2.065e-14 |
0.49
|
| CNR1_HUMAN |
CNR1 |
Cannabinoid receptor 1 |
6.173e-14 |
0.47
|
| V1BR_RAT |
Avpr1b |
Vasopressin V1b receptor |
2.656e-13 |
0.30
|
| PADI4_HUMAN |
PADI4 |
Protein-arginine deiminase type-4 |
3.894e-13 |
0.31
|
| BKRB1_RAT |
Bdkrb1 |
B1 bradykinin receptor |
8.894e-13 |
0.34
|
| CALRL_HUMAN |
CALCRL |
Calcitonin gene-related peptide type 1 receptor |
1.409e-12 |
0.32
|
| CSK2A_MAIZE |
ACK2 |
Casein kinase II subunit alpha |
2.793e-12 |
0.29
|
| PARP1_HUMAN |
PARP1 |
Poly [ADP-ribose] polymerase 1 |
2.913e-11 |
0.37
|
| IKKA_HUMAN |
CHUK |
Inhibitor of nuclear factor kappa-B kinase subunit alpha |
6.81e-10 |
0.39
|
| ACACB_HUMAN |
ACACB |
Acetyl-CoA carboxylase 2 |
1.367e-09 |
0.36
|
| HRH3_RAT |
Hrh3 |
Histamine H3 receptor |
4.149e-09 |
0.36
|
| DCPS_MOUSE |
Dcps |
m7GpppX diphosphatase |
4.515e-09 |
0.28
|
| NK2R_RABIT |
TACR2 |
Substance-K receptor |
5.276e-09 |
0.30
|
| HRH1_HUMAN |
HRH1 |
Histamine H1 receptor |
8.099e-09 |
0.36
|
| SGMR1_RAT |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
1.963e-08 |
0.33
|
| SPHK2_MOUSE |
Sphk2 |
Sphingosine kinase 2 |
2.018e-08 |
0.29
|
| CCR5_HUMAN |
CCR5 |
C-C chemokine receptor type 5 |
2.067e-08 |
0.33
|
| AL1A1_HUMAN |
ALDH1A1 |
Retinal dehydrogenase 1 |
2.201e-08 |
0.32
|
| PA2GA_HUMAN |
PLA2G2A |
Phospholipase A2, membrane associated |
4.247e-08 |
0.31
|
| CCNC_HUMAN |
CCNC |
Cyclin-C |
6.226e-08 |
0.32
|
| MK07_HUMAN |
MAPK7 |
Mitogen-activated protein kinase 7 |
6.668e-08 |
0.38
|
| REV_HV1H2 |
rev |
Protein Rev |
7.347e-08 |
0.31
|
| OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
7.883e-08 |
0.35
|
| Q5J463_SALCH |
tem-1 |
Beta-lactamase |
1.023e-07 |
0.31
|
| Q9BJF5_TOXGO |
CDPK1 |
Calmodulin-domain protein kinase 1 |
1.415e-07 |
0.30
|
| NMT_CANAL |
NMT1 |
Glycylpeptide N-tetradecanoyltransferase |
2.185e-07 |
0.31
|
| ACM1_HUMAN |
CHRM1 |
Muscarinic acetylcholine receptor M1 |
3.827e-07 |
0.42
|
| OPRK_HUMAN |
OPRK1 |
Kappa-type opioid receptor |
5.126e-07 |
0.35
|
| DHI1_HUMAN |
HSD11B1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 |
8.513e-07 |
0.32
|
| Q8JXU8_9HEPC |
NS5B |
RNA-directed RNA polymerase |
1.001e-06 |
0.35
|
| NK1R_CAVPO |
TACR1 |
Substance-P receptor |
1.103e-06 |
0.30
|
| P2Y12_HUMAN |
P2RY12 |
P2Y purinoceptor 12 |
1.372e-06 |
0.32
|
| Q70GC6_9HEPC |
NS5B |
RNA-directed RNA polymerase |
1.754e-06 |
0.30
|
| ACM1_RAT |
Chrm1 |
Muscarinic acetylcholine receptor M1 |
2.389e-06 |
0.32
|
| OXYR_HUMAN |
OXTR |
Oxytocin receptor |
8.001e-06 |
0.30
|
| HCAR3_HUMAN |
HCAR3 |
Hydroxycarboxylic acid receptor 3 |
8.435e-06 |
0.32
|